Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of FibroGen Inc (NASDAQ: FGEN) was $0.31 for the day, down -4.33% from the previous closing price of $0.33. In other words, the price has decreased by -$4.33 from its previous closing price. On the day, 2.29 million shares were traded. FGEN stock price reached its highest trading level at $0.3418 during the session, while it also had its lowest trading level at $0.303.
Ratios:
Our analysis of FGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.45 and its Current Ratio is at 1.47.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2023, Downgraded its rating to Underperform and sets its target price to $2 from $4 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 24 ’25 when Wettig Thane bought 145,000 shares for $0.35 per share. The transaction valued at 50,663 led to the insider holds 543,329 shares of the business.
Schoeneck James A bought 250,000 shares of FGEN for $88,000 on Mar 20 ’25. The Director now owns 323,722 shares after completing the transaction at $0.35 per share. On Mar 21 ’25, another insider, Schoeneck James A, who serves as the Director of the company, bought 50,000 shares for $0.34 each. As a result, the insider paid 17,040 and bolstered with 373,722 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FGEN now has a Market Capitalization of 31667756 and an Enterprise Value of 113326744. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.20. Its current Enterprise Value per Revenue stands at 3.826 whereas that against EBITDA is -0.884.
Stock Price History:
The Beta on a monthly basis for FGEN is 0.85, which has changed by -0.86694914 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, FGEN has reached a high of $2.59, while it has fallen to a 52-week low of $0.18. The 50-Day Moving Average of the stock is -32.05%, while the 200-Day Moving Average is calculated to be -40.29%.
Shares Statistics:
FGEN traded an average of 3.58M shares per day over the past three months and 1930130 shares per day over the past ten days. A total of 100.92M shares are outstanding, with a floating share count of 93.80M. Insiders hold about 7.06% of the company’s shares, while institutions hold 36.10% stake in the company. Shares short for FGEN as of 1741910400 were 4978990 with a Short Ratio of 1.39, compared to 1739491200 on 2946557. Therefore, it implies a Short% of Shares Outstanding of 4978990 and a Short% of Float of 5.8000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
